{"id":"https://openalex.org/W3096518940","doi":"https://doi.org/10.1182/blood-2020-142074","title":"Phase II Study of CPX-351 Plus Venetoclax in Patients with Acute Myeloid Leukemia (AML)","display_name":"Phase II Study of CPX-351 Plus Venetoclax in Patients with Acute Myeloid Leukemia (AML)","publication_year":2020,"publication_date":"2020-11-04","ids":{"openalex":"https://openalex.org/W3096518940","doi":"https://doi.org/10.1182/blood-2020-142074","mag":"3096518940"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-142074","doi":"https://doi.org/10.1182/blood-2020-142074","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-142074","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020340537","display_name":"Tapan Mahendra Kadia","orcid":"https://orcid.org/0000-0002-9892-9832","observed_orcids":["https://orcid.org/0000-0002-9892-9832"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tapan M. Kadia","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055045706","display_name":"Gautam M. Borthakur","orcid":"https://orcid.org/0000-0001-7679-6453","observed_orcids":["https://orcid.org/0000-0001-7679-6453"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gautam Borthakur","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051949215","display_name":"Koichi Takahashi","orcid":"https://orcid.org/0000-0002-8027-9659","observed_orcids":["https://orcid.org/0000-0002-8027-9659"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koichi Takahashi","raw_affiliation_strings":["Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010786159","display_name":"Courtney Denton Dinardo","orcid":"https://orcid.org/0000-0001-9003-0390","observed_orcids":["https://orcid.org/0000-0001-9003-0390"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney D. DiNardo","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035605515","display_name":"Naval Guastad Daver","orcid":"https://orcid.org/0000-0001-7103-373X","observed_orcids":["https://orcid.org/0000-0001-7103-373X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naval Daver","raw_affiliation_strings":["Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088307376","display_name":"Naveen Pemmaraju","orcid":"https://orcid.org/0000-0002-1670-6513","observed_orcids":["https://orcid.org/0000-0002-1670-6513"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naveen Pemmaraju","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049385583","display_name":"Elias Joseph Jabbour","orcid":"https://orcid.org/0000-0003-4465-6119","observed_orcids":["https://orcid.org/0000-0003-4465-6119"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elias Jabbour","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021380291","display_name":"Nitin Jain","orcid":"https://orcid.org/0000-0003-0114-8384","observed_orcids":["https://orcid.org/0000-0003-0114-8384"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nitin Jain","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091492845","display_name":"Nicholas James Short","orcid":"https://orcid.org/0000-0002-2983-2738","observed_orcids":["https://orcid.org/0000-0002-2983-2738"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas J. Short","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088821817","display_name":"Wei Qiao","orcid":"https://orcid.org/0000-0002-0922-0726","observed_orcids":["https://orcid.org/0000-0002-0922-0726"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Qiao","raw_affiliation_strings":["Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034225186","display_name":"Lade Adewale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lade Adewale","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050975340","display_name":"Caitlin R. Rausch","orcid":"https://orcid.org/0000-0002-4166-5717","observed_orcids":["https://orcid.org/0000-0002-4166-5717"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caitlin R. Rausch","raw_affiliation_strings":["Pharmacy, MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy, MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030500582","display_name":"Sherry A. Pierce","orcid":"https://orcid.org/0000-0002-9542-1558","observed_orcids":["https://orcid.org/0000-0002-9542-1558"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sherry A. Pierce","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070065917","display_name":"Yesid Alvarado","orcid":"https://orcid.org/0000-0002-1652-7937","observed_orcids":["https://orcid.org/0000-0002-1652-7937"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yesid Alvarado","raw_affiliation_strings":["Department of Leukemia, MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034104852","display_name":"Amin Majid Alousi","orcid":"https://orcid.org/0000-0002-2498-8573","observed_orcids":["https://orcid.org/0000-0002-2498-8573"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amin M. Alousi","raw_affiliation_strings":["Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066894053","display_name":"Uday Popat","orcid":"https://orcid.org/0000-0002-7592-2224","observed_orcids":["https://orcid.org/0000-0002-7592-2224"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Uday R. Popat","raw_affiliation_strings":["Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033737136","display_name":"Issa F. Khouri","orcid":"https://orcid.org/0000-0003-2473-911X","observed_orcids":["https://orcid.org/0000-0003-2473-911X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Issa F. Khouri","raw_affiliation_strings":["Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022647201","display_name":"Marina Y Konopleva","orcid":"https://orcid.org/0000-0002-9347-2212","observed_orcids":["https://orcid.org/0000-0002-9347-2212"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marina Konopleva","raw_affiliation_strings":["Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015101485","display_name":"J\u00f6rge E. Cortes","orcid":"https://orcid.org/0000-0002-8636-1071","observed_orcids":["https://orcid.org/0000-0002-8636-1071"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jorge E. Cortes","raw_affiliation_strings":["Georgia Cancer Center Augusta University, Augusta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Cancer Center Augusta University, Augusta, GA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000750846","display_name":"Farhad Ravandi","orcid":"https://orcid.org/0000-0002-7621-377X","observed_orcids":["https://orcid.org/0000-0002-7621-377X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Farhad Ravandi","raw_affiliation_strings":["Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.4197,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.83189946,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"20","last_page":"22"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cpx-351","display_name":"CPX-351","score":0.9729999899864197},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9789999723434448},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9860000014305115},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.9049999713897705},{"id":"https://openalex.org/keywords/newly-diagnosed-aml","display_name":"newly diagnosed AML","score":0.9629999995231628},{"id":"https://openalex.org/keywords/liposomal-cytarabine","display_name":"liposomal cytarabine","score":0.8349999785423279},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.9110000133514404},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.593999981880188},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8220000267028809},{"id":"https://openalex.org/keywords/cyp3a-inhibitors","display_name":"CYP3A inhibitors","score":0.6650000214576721},{"id":"https://openalex.org/keywords/relapsed-aml","display_name":"relapsed AML","score":0.6439999938011169},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9216232299804688},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.659744143486023},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5845468044281006},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4662211239337921},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.45887935161590576},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4126732349395752},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.410592645406723},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.24620524048805237},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.09326443076133728}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-142074","doi":"https://doi.org/10.1182/blood-2020-142074","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-142074","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3214589663","https://openalex.org/W4389222765","https://openalex.org/W4405040730","https://openalex.org/W4389233985","https://openalex.org/W4405039545","https://openalex.org/W3212583391","https://openalex.org/W4410600819","https://openalex.org/W4415430191","https://openalex.org/W4403480209","https://openalex.org/W4417021308"],"abstract_inverted_index":{"Background":[0],"CPX-351":[1,41,72,117,126,562],"is":[2,17,568],"a":[3,12,188,291,323,464],"liposomal":[4],"formulation":[5],"of":[6,23,71,79,83,113,125,139,158,175,181,198,294,325,423,448,468,498,530,566,768,791,805,828,842,859,873,897,909,921,933,945,957,969,981,994,1111,1128,1145,1157,1172,1189,1208,1227,1243,1257,1272],"cytarabine":[7],"(araC)":[8],"and":[9,49,98,111,141,195,209,231,245,254,276,310,330,358,390,416,477,481,484,488,502,510,516,537,559,615],"daunorubicin":[10],"at":[11],"fixed":[13],"molar":[14],"ratio":[15],"that":[16],"currently":[18],"approved":[19],"for":[20,169,202,206,249,257,392,406,420,454],"the":[21,84,109,163,170,302,474,482,496,526,531],"treatment":[22],"patients":[24,54,119,176,216,284,574],"with":[25,55,116,120,177,217,251,259,264,290,322,334,355,361,367,382,402,463,570,575],"therapy-related":[26],"AML":[27,30,75,253,321,369,385,404,582],"or":[28,770,793,807,830,844,861,875,899,911,923,935,947,959,971,983,996,1113,1130,1147,1159,1174,1191,1210,1229,1245,1259,1274],"secondary":[29],"(s-AML)":[31],"arising":[32],"from":[33],"prior":[34,277,328,371,388,432,445,506,597],"myelodysplastic":[35],"syndrome":[36],"(MDS).":[37],"Compared":[38],"to":[39,89,95,107,242,436,604,607,612],"7+3,":[40],"demonstrated":[42,76,587],"higher":[43],"response":[44],"rates":[45,513],"(ORR),":[46],"better":[47,50],"tolerability,":[48],"survival":[51],"(OS)":[52],"in":[53,73,118,301,307,313,343,376,429,544,573,591],"s-AML.":[56],"The":[57,68,123,154,379,456,508,519,547,609],"OS":[58,99,458,466,476,497],"benefit":[59],"was":[60,93,127,160,185,193,225,235,280,409,426,460,524],"also":[61],"observed":[62],"after":[63,183],"stem":[64],"cell":[65],"transplant":[66],"(SCT).":[67],"dose-finding":[69],"study":[70,106,275,610],"R/R":[74,178,252,320,368,403,576],"an":[77,395,421,765,788,802,825,839,856,870,894,906,918,930,942,954,966,978,991,1108,1125,1142,1154,1169,1186,1205,1224,1240,1254,1269],"ORR":[78,97,422,425],"23%.":[80],"Recently,":[81],"addition":[82],"BCL-2":[85],"inhibitor":[86],"venetoclax":[87],"(Ven)":[88],"hypomethylating":[90],"agents":[91],"(HMAs)":[92],"shown":[94],"improve":[96],"over":[100],"HMAs":[101],"alone.":[102],"We":[103],"designed":[104],"this":[105,579],"investigate":[108],"safety":[110,171,234,244],"efficacy":[112],"Ven":[114,159,182,203,278,433,567,586],"combined":[115],"AML.":[121,179,262,338,577],"Methods":[122],"dose":[124,157,165,222,521,529],"constant:":[128],"(daunorubicin":[129,142],"44":[130],"mg/m2":[131,144],"+":[132,145,585],"araC":[133,146],"100":[134],"mg/m2)":[135,148],"IV":[136,149],"on":[137,150,167,229,274,288,453,606,764,787,801,824,838,855,869,893,905,917,929,941,953,965,977,990,1107,1124,1141,1153,1168,1185,1204,1223,1239,1253,1268],"D1,3,5":[138],"induction":[140],"29":[143],"65":[147],"D1,3":[151],"during":[152],"consolidation.":[153],"starting":[155,520],"effective":[156],"300mg":[161,228],"(at":[162],"-1":[164,523],"level)":[166],"D2-21":[168],"lead-in":[172,303],"cohort,":[173,304,583],"composed":[174],"Interruption":[180],"D14":[184,189],"allowed":[186,273],"if":[187],"bone":[190],"marrow":[191],"(BM)":[192],"hypocellular":[194],"without":[196,431],"evidence":[197],"leukemia.":[199],"Dose":[200],"adjustments":[201],"were":[204,240,272,479,486,514,534,555,602],"made":[205],"concomitant":[207],"moderate":[208],"strong":[210],"CYP3A":[211],"inhibitors.":[212],"Upon":[213],"encountering":[214],"3/6":[215],"DLT":[218],"(cytopenias":[219],">43":[220],"days),":[221],"level":[223,522],"-2":[224],"explored":[226],"(Ven":[227],"D2-8)":[230],"expanded.":[232],"Once":[233],"confirmed,":[236],"two":[237],"expansions":[238],"cohorts":[239],"opened":[241],"confirm":[243],"efficacy:":[246],"Cohort":[247,255,308],"A":[248,309],"pts":[250,258,348,366,401,430,450,499],"B":[256],"newly":[260,335,383],"diagnosed":[261,336,384],"Patients":[263],"adequate":[265],"organ":[266],"function,":[267],"ECOG":[268],"PS":[269],"<":[270],"2":[271,326],"exposure":[279],"allowed.":[281],"Results":[282],"18":[283],"have":[285],"been":[286],"treated":[287],"study,":[289],"median":[292,324,457,475],"age":[293],"51":[295],"yrs":[296],"(range,":[297],"29-71):":[298],"12":[299],"(67%)":[300],"5":[305,413],"(28%)":[306],"1":[311,331,380,410,417],"(6%)":[312,332,411,418],"cohort":[314],"B.":[315],"Overall":[316],"17":[317],"(94%)":[318],"had":[319,349,370,387,444,594],"(1-8)":[327],"therapies,":[329],"patient":[333],"treated-secondary":[337],"Patient":[339],"characteristics":[340],"are":[341,374,542],"summarized":[342,375,543],"Table":[344,377,545],"1.":[345,378],"Nine":[346],"(50%)":[347],"adverse":[350,540,553],"karyotype":[351,357],"including":[352],"6":[353,359],"(33%)":[354,360],"complex":[356],"TP53":[362],"mutations;":[363],"7":[364,564],"(41%)":[365],"Ven.":[372,446,507,598],"Outcomes":[373],"pt":[381],"(who":[386],"HMA+Ven":[389],"SCT":[391],"MDS)":[393],"achieved":[394],"MRD":[396],"(-)":[397],"CR.":[398],"Of":[399],"16":[400],"evaluable":[405],"response,":[407],"there":[408],"CR,":[412],"(31%)":[414],"CRi,":[415],"MLFS":[419],"44%.":[424],"60%":[427],"(6/10)":[428],"exposure,":[434],"compared":[435],"just":[437],"17%":[438],"(1/6":[439],"evaluable)":[440],"among":[441],"those":[442,592],"who":[443,500,593],"86%":[447,487],"responding":[449],"(6/7)":[451],"went":[452],"SCT.":[455,608],"overall":[459],"6.4":[461],"months":[462],"6m":[465],"rate":[467],"53%":[469],"(Figure":[470,491],"1).":[471],"Among":[472],"responders,":[473],"RFS":[478,485],"NR":[480],"6m-OS":[483],"86%,":[489],"respectively":[490],"2).":[492],"Figure":[493],"3":[494],"shows":[495],"did":[501,503],"not":[504,595],"receive":[505],"4-":[509],"8-week":[511],"mortality":[512],"11%":[515],"22%,":[517],"respectively.":[518],"above":[525],"maximum":[527],"tolerated":[528],"combination;":[532],"DLTs":[533],"prolonged":[535],"neutropenia":[536],"thrombocytopenia.":[538],"Serious":[539],"events":[541,554],"2.":[546],"most":[548],"frequent":[549],"grade":[550],"3/4":[551],"serious":[552],"infection,":[556],"nausea,":[557],"pneumonia,":[558],"myelosuppression.":[560],"Conclusion":[561],"plus":[563],"days":[565],"tolerable,":[569],"acceptable":[571],"toxicities":[572],"Within":[578],"high":[580],"risk":[581],"CPX":[584],"encouraging":[588],"activity,":[589],"particularly":[590],"received":[596],"Almost":[599],"all":[600],"responders":[601],"able":[603],"move":[605],"continues":[611],"enroll":[613],"relapsed":[614],"frontline":[616],"cohorts.":[617],"Disclosures":[618],"Kadia:":[619],"Astellas:":[620,835,1289],"Research":[621,624,627,631,636,639,642,645,649,652,656,660,664,668,672,675,678,681,684,687,690,694,697,700,703,707,710,739,744,757,774,781,796,810,813,816,819,833,847,850,864,878,881,885,888,999,1011,1014,1020,1035,1039,1051,1056,1059,1066,1072,1078,1084,1090,1096,1102,1116,1119,1133,1136,1162,1177,1180,1194,1198,1213,1217,1234,1248,1263,1277,1283,1290,1294,1298,1302,1305,1309,1312,1316],"Funding;":[622,625,628,632,637,640,643,646,650,653,657,661,665,673,676,679,682,685,688,691,695,698,701,704,708,711,740,745,758,775,797,811,814,817,820,834,848,851,865,879,882,886,889,1012,1015,1021,1036,1040,1052,1057,1067,1073,1079,1085,1091,1097,1117,1120,1134,1137,1163,1178,1181,1195,1199,1214,1218,1235,1249,1264,1284,1295,1299,1303,1306,1310,1313,1317],"Celgene:":[623,754,902,1044],"Pulmotec:":[626],"Astra":[629],"Zeneca:":[630],"Novartis:":[633,677,752,890,1049],"Honoraria;":[634,747,749,751,760,777,1005,1008,1024,1027,1043,1045,1048,1288],"Incyte:":[635,674,1135],"Cellenkos:":[638],"Ascentage:":[641],"Amgen:":[644,866,950,1098,1287],"BMS:":[647,696,1080,1118],"Honoraria,":[648,655,659,663,667,738,743,756,780,1034,1050,1055,1105,1122,1139,1151,1166,1183,1202,1221,1237,1251,1266,1282],"Cyclacel:":[651,689],"Pfizer:":[654,798,1092,1179],"JAZZ:":[658],"Genentech:":[662,818,1086],"Abbvie:":[666,680],"Funding.":[669,782,1000,1060,1103,1278,1291],"Borthakur:PTC":[670],"Therapeutics:":[671,717,722,730,733,884,1010,1054,1197,1216,1220,1233],"Jannsen:":[683],"GSK:":[686],"BioLine":[692,724],"Rx:":[693,725],"AstraZeneca:":[699,1265,1285],"Polaris:":[702],"Xbiotech":[705],"USA:":[706],"Oncoceutics:":[709],"Curio":[712],"Science":[713],"LLC:":[714],"Consultancy;":[715,718,720,723,726,728,731,753,1003,1286],"FTC":[716],"Argenx:":[719],"PTC":[721],"BioTherix:":[727],"Nkarta":[729],"Treadwell":[732],"Consultancy.":[734],"DiNardo:Daiichi":[735],"Sankyo:":[736,987,1038],"Consultancy,":[737,742,755,779,785,799,822,836,853,867,891,903,915,927,939,951,963,975,988,1281],"Agios:":[741,974],"Jazz:":[746,914],"Takeda:":[748,1074],"Syros:":[750],"MedImmune:":[759],"Notable":[761],"Labs:":[762],"Membership":[763,786,800,823,837,854,868,892,904,916,928,940,952,964,976,989,1106,1123,1140,1152,1167,1184,1203,1222,1238,1252,1267],"entity's":[766,789,803,826,840,857,871,895,907,919,931,943,955,967,979,992,1109,1126,1143,1155,1170,1187,1206,1225,1241,1255,1270],"Board":[767,790,804,827,841,858,872,896,908,920,932,944,956,968,980,993,1110,1127,1144,1156,1171,1188,1207,1226,1242,1256,1271],"Directors":[769,792,806,829,843,860,874,898,910,922,934,946,958,970,982,995,1112,1129,1146,1158,1173,1190,1209,1228,1244,1258,1273],"advisory":[771,794,808,831,845,862,876,900,912,924,936,948,960,972,984,997,1114,1131,1148,1160,1175,1192,1211,1230,1246,1260,1275],"committees;":[772,901,913,925,937,949,961,973,985,1149,1231,1261],"Calithera:":[773],"ImmuneOnc:":[776],"AbbVie:":[778,821,1033,1068,1121],"Daver:Bristol-Myers":[783],"Squibb:":[784],"committees,":[795,809,832,846,863,877,998,1115,1132,1161,1176,1193,1212,1247,1276],"Karyopharm:":[812],"Servier:":[815,1150],"Novimmune:":[849],"Gilead:":[852],"Trovagene:":[880],"Fate":[883,1232],"ImmunoGen:":[887],"Trillium:":[926],"Syndax:":[938],"KITE:":[962],"Daiichi":[986,1037],"Pemmaraju:Pacylex":[1001],"Pharmaceuticals:":[1002,1301,1308],"MustangBio:":[1004],"DAVA":[1006],"Oncology:":[1007,1280],"Samus":[1009],"Cellectis:":[1013,1262],"Affymetrix:":[1016],"Other:":[1017,1030,1063,1069,1075,1081,1087,1093,1099],"Grant":[1018,1031],"Support,":[1019],"Roche":[1022],"Diagnostics:":[1023],"Incyte":[1025],"Corporation:":[1026],"SagerStrong":[1028],"Foundation:":[1029],"Support;":[1032],"LFB":[1041],"Biotechnologies:":[1042,1062,1165],"Blueprint":[1046],"Medicines:":[1047],"Stemline":[1053],"Plexxikon:":[1058],"Jabbour:Adaptive":[1061],"Advisory":[1064,1070,1076,1082,1088,1094,1100],"role,":[1065,1071,1077,1083,1089,1095,1101],"Jain:Genentech:":[1104],"BeiGene:":[1138],"Adaptive":[1164],"Verastem:":[1182],"Aprea":[1196],"Precision":[1200],"Bioscienes:":[1201],"ADC":[1215],"TG":[1219],"Pharmacyclics:":[1236],"Janssen:":[1250],"Short:Takeda":[1279],"Alvarado:MEI":[1292],"Pharma:":[1293,1315],"BerGenBio":[1296],"ASA:":[1297],"Tolero":[1300],"Daiichi-Sankyo:":[1304],"Astex":[1307],"FibroGen:":[1311],"Sun":[1314],"Jazz":[1318],"Pharmac":[1319]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":7}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2020-11-09T00:00:00"}